68-5

7/120

(−)29834863(+)344141485(=TP/[TP+FN]), Figure 8　Transverse view : prostate cancer localization and transperineal prostate biopsyProf. Ryuichi Kitagawa（Died in 2020）Figure 9　Three chief professors and two directors who were my mentorsEmeritus Director Takeshi MiyanoProf. Makoto FujimeDirector Kuniaki KojimaTable 1　Prostate cancer localization in the Apex, Apex–Mid, Mid, Mid–Base, and Base out of the 121 casesRegionApexApex–MidMidMid–BaseBaseNinety-nine point two percent of all cancer cases were detected in the Apex and Apex–Mid regions, 95.5% was detected in the Apex–Mid and Mid regions, and 84.3% was detected in the Mid and Mid–Base regions.Table 2　Concordance of prostate cancer in prostatectomy specimen and biopsyProf. Shigeo Horie457Biopsy (+)Biopsy (−)TotalSensitivity (=TN/[FP+TN]), 96.6%; positive predictive value (=TP/[TP+FP]), 92.2%; negative predictive value (=TN/[TN+FN]), 85.5%.True positive (TP)　False positive (FP)False negative (FN)　True negative (TN)No. of cases of prostate cancer positive (%)Prostate cancer Prostate cancer 70.9%; 93 (76.9)115 (95.0)101 (83.5)71 (58.7)23 (19.0)Total3739751,348specificity